⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24593147 | 0.64 | — | — | |
| SCHEMBL17628492 | 0.61 | — | — | |
| SCHEMBL3362487 | 0.60 | — | — | |
| SCHEMBL4239080 | 0.58 | — | — | |
| SCHEMBL7153495 | 0.58 | — | — | |
| SCHEMBL5162202 | 0.56 | — | — | |
| SCHEMBL392704 | 0.55 | — | — | |
| SCHEMBL28922994 | 0.55 | CYP2C19 (0.31) | — | |
| SCHEMBL28922992 | 0.55 | — | — | |
| Propylene Glycol SCHEMBL9334472 | 0.55 | TDP1 (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3697758-B1 | SULPHONAMIDES AND COMPOSITIONS THEREOF FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY | NOVARTIS AG (CH) | 2022-07-06 | — | — | EP | disclosed |